Dopamine receptor D2 Ser/Cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses

Molecular Psychiatry

Volumn 5, Issue 3, 2000, Pages 270-274

  Serretti, A ^a   Lattuada, E ^a   Lorenzi, C ^a   Lilli, R ^a   Smeraldi, E ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Bipolar disorder; Depressive disorder; Dopamine receptors; Linkage disequilibrium; Paranoid disorder; Psychopathology; Schizophrenia

Indexed keywords

CYSTEINE; DOPAMINE 2 RECEPTOR; PSYCHOTROPIC AGENT; RECEPTOR SUBTYPE; SERINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DELUSION; DEPRESSION; DISORIENTATION; DRUG BINDING SITE; FEMALE; GENETIC RISK; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; ONSET AGE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SEX DIFFERENCE; SYMPTOMATOLOGY;

EID: 0033934091     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000726     Document Type: Article

References (64)

1. Willner P. Dopaminergic mechanisms in depression and mania. In: Bloom F, Kupfer D (eds). Psychopharmacology, the Fourth Generation of Progress. Raven Press: New York, 1995, pp 921-931.
2. Grandy D, Litt M, Allen L, Bunzow J, Marchionni M, Makam H et al. The human D2 dopamine receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet 1989; 45: 778-785.
3. Itokawa M, Arinami T, Futamura N, Hamaguchi H, Toru M. A Structural polymorphism of human dopamine D2 receptor, D2 (Ser311-Cys). Biochem Biophys Res Commun 1993; 196: 1369-1375.
4. Jonsson E, Sedvall G, Brene S, Gustavsson JP, Geijer T, Terenius L et al. Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biol Psychiatry 1996; 40: 1032-1043.
5. Arinami T, Itokawa M, Enguchi H, Tagaya H, Yano S, Shimizu H et al. Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet 1994; 343: 703-704.
6. Nanko S, Hattori M, Dai XY, Fukuda R, Kazamatsuri H. DRD2 Ser311/Cys311 polymorphism in schizophrenia. Lancet 1994; 343: 1044.
7. Nothen MM, Wildenauer D, Cichon S, Albus M, Maier W, Minges } et al. Dopamine D2 receptor molecular variant and schizophrenia. Lancet 1994; 343: 1301-1302.
8. Chen CH, Chien SH, Hwu HG. No association of dopamine D2 receptor molecular variant Cys311 and schizophrenia in Chinese patients. Am J Med Gen 1996; 67: 418-420.
9. Crawford F, Hoyne J, Cai X, Osborne A, Poston D, Zaglul J et al. Dopamine DRD2/Cys311 is not associated with chronic schizophrenia. Am J Med Gen 1996; G7: 483-484.
10. Goldman D, Urbanek M, Guenther D, Robin R, Long JC. Linkage and association of a functional DRD2 variant [Ser31lCys] and DRD2 markers to alcoholism, substance abuse and schizophrenia in Southwestern American Indians. Am J Med Gen 1997; 74: 386-394.
11. Laurent C, Bodeau-Pean S, Campion D, d'Amato T, Jay M, Dollfus S et al. No major role for the dopamine D2 receptor Ser→Cys311 mutation in schizophrenia. Psychiatr Genet 1994; 4: 229-230.
12. Sobell J, Sigurdson D, Heston L, Sommer S. S311C D2DR variant: no association with schizophrenia. Lancet 1994; 344: 621-622.
13. Tanaka T, Igarashi S, Onodera O, Tanaka H, Fiikushima N, Takahashi M et al. Lack of association between dopamine D2 receptor gene Cys311 variant and schizophrenia. Am {Mod Gen 1996; 67: 208-211.
14. Verga M, Macciardi F, Pedrini S, Cohen S, Smeraldi E. No association of the Ser/Cys311 DRD2 molecular variant with schizophrenia using a classical case control study and the haplotype relative risk. SchizophrRes 1997; 25: 117-121.
15. Shaikh S, Collier D, Arranz M, Ball D, Gill M, Kerwin R. DRD2 Ser311/Cys311 polymorphism in schizophrenia. Lancet 1994; 343: 1045-1046.
16. Pearlson GD, Wong DF, Tune LE, Ross CA, Chase GA, Links JM et al. In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder. Arch Gen Psychiatry 1995; 52: 471-477.
17. Smith M, Wasmuth J, McPherson J, Wagner C, Grandy D, Civelli O et al. Cosegregation of an Hq22.3-9q22 translocation with affective disorder: proximity of the dopamine D2 receptor gene relative to the translocation breakpoint. Am J Hum Genet 1989; 45 (suppl): A220.
18. Balk J, Picetti R, Salardi A, Thirlet G, Dierich A, Depaulls A et al. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 1995; 377: 424-428.
19. Arinami T, Itokawa M, Aoki J, Shibuya H, Ookubo Y, Iwawaki A et al. Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorders. Am J Med Gen 1996; 67: 133-138.
20. Byerley W, Leppert M, O'Connell P, Mellon C, Holik J, Lubbers A et al. D2 Dopamine receptor not linked to manic-depression in three families. Psych Genet 1990; 1: 55-62.
21. Holmes D, Brynjolfsson J, Brett P, Curtis D, Petursson H, Sherrington R et al. No evidence for a susceptibility locus predisposing to manic depression in the region of the dopamine D2 receptor gene. Br Psych 1991; 158: 635-641.
22. Mitchell P, Selbie L, Waters B, Donald J, Vivero C, Tully M et al Exclusion of close linkage of bipolar disorder to the dopamine D1 and D2 receptor gene markers. J Aff Dis 1992; 25: 1-12.
23. Nöthen M, Erdmann J, Körner J, Lanczik M, Fritze J, Fimmers R et al. Lack of association between dopamine D1 and D2 receptor genes and bipolar affective disorder. Am J Psych 1992; 140: 199-201.
24. Debruyn A, Mendelbaum K, Sandkuijl L, Delvenne V, Hirsch D, Staner L et al. Nonlinkage of bipolar illness to tyrosine hydroxylase, tyrosinase, and D2 and D4 dopamine receptor genes on chromosome 11. Am J Psychiatry 1994; 151: 102-106.
25. Nanko S, Fukuda R, Hattori M, Sasaki T, Dai XY, Kanba S et al. Linkage studies between affective disorder and dopamine D2, D3, and D4 receptor gene loci in four Japanese pedigrees. Psychiatry Res 1994; 52: 149-157.
26. Craddock N, Roberts Q, Williams N, McGuffin P, Owen MJ. Association study of bipolar disorder using a functional polymorphism (SerSll-Cys) in the dopamine D2 receptor gene. Psychiatr Genet 1995; 5: 63-65.
27. Oruc L, Furac I, Croux C, Jakovljevic M, Kracun I, Folnegovic V et al. Association study between bipolar disorder and candidate genes involved in dopamine-serotonin metabolism and GABAergic neurotransmission: a preliminary report. Psychiatr Genet 1996; 6: 213-217.
28. Souery D, Lipp O, Mahieu B, Mendelbaum K, De Martelaer V, Van Broeckhoven C et al. Association study of bipolar disorder with candidate genes involved in catecholamine neurotransmission: DRD2, DRD3, DAT1, and TH genes. Am J Mod Gen 1996; 67: 551-555.
29. Ferez de Castro I, Santos J, Torres P, Visedo G, Saiz-Ruiz J, Llinares C et al. A weak association between TH and DRD2 genes and bipolar affective disorder in a Spanish sample. J Med Gen 1995;. 32: 131-134.
30. Cloninger C. Turning point in the design of linkage studies of schizophrenia. Am J Med Gen 1994; 54: 83-92.
31. Ginsburg B, Werick T, Escobar J, Kugelmass S. Molecular genetics of psychopathologies: a search for simple answers to complex problems. Behav Genet 1996; 26: 325-333.
32. Tsuang M, Faraone S. The Genetics of Mood Disorders. The Johns Hopkins University Press: Baltimore, 1990.
33. Cloninger C, Adolfsson R, Svrakic N. Mapping genes for human personality. Nat Genet 1996; 12: 3-4.
34. Comings DE. Polygenic inheritance in psychiatric disorders. In: Blum K, Noble EP (eds). Handbook of Psychiatric Genetics. CRC Press: Boca Raton, 1997, pp 235-260.
35. Risch N. Linkage strategies for genetically complex traits: I. Multilocus models. Am J Med Gen 1990; 40: 222-228.
36. Serretti A, Macciardi F, Smeraldi E. Identification of Symptomatologie patterns common to major psychoses: proposal for a phonotype definition. Am J Med Gen 1996; 67: 393-400.
37. Liddle PF. The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. Br J Psychiatry 1987; 151: 145-151.
38. Andreasen NC, Arndt S, Alliger R, Miller D, Flaum M. Symptoms of schizophrenia. Methods, meanings, and mechanisms. Arch Gen Psychiatry 1995; 52: 341-351.
39. Liddle PF, Barnes TRE. Syndromes of chronic schizophrenia. Br J Psychiatry 1990; 157: 558-501.
40. Peralta V, de Leon J, Cuesta MJ. Are there more than two syndromes in schizophrenia? A critique of the positive-negative dichotomy. Br Psychiatry 1992; 161: 335-343.
41. Maziade M, Roy MA, Martinez M, Cliche D, Fournier JP, Garneau Y et al. Negative, psychoticism, and disorganized dimensions in patients with familial schizophrenia or bipolar disorder: continuity and discontinuity between the major psychoses. Am J Psychiatry 1995; 152: 1458-1463.
42. Van Os J, Marcelis M, Sham P, Jones P, Gilvarry K, Murray R. Psychopathological syndromes and familial morbid risk of psychosis. Br J Psychiatry 1997; 170: 241-246.
43. Van Os J, Fahy TA, Jones P, Harvey I, Sham P, Lewis S et al. Psychopathological syndromes in the functional psychoses: associations with course and outcome. Psychol Med 1996; 20: 161-176.
44. Burke JG, Murphy BM, Bray JC, Walsh D, Kendler KS. Clinical similarities in siblings with schizophrenia. Am J Med Gen 1996; 07: 239-243.
45. Kendler KS, Karkowski-Shuman L, FA ON, Straub RE, MacLean CJ, Walsh D. Resemblance of psychotic symptoms and syndromes in affected sibling pairs from the Irish Study of High-Density Schizophrenia Families: evidence for possible etiologic heterogeneity. Am J Psychiatry 1997; 154: 191-198.
46. Loftus J, DeLisi LE, Crow TJ. Familial associations of subsyndromes of psychosis in affected sibling pairs with schizophrenia and schizoaffective disorder. Psychiatry Res 1998; 80: 101-111.
47. Cardno AG, Holmans PA, Harvey I, Williams MB, Owen MJ, McGuffin P. Factor-derived subsyndromes of schizophrenia and familial morbid risks. Schizophr fies 1997; 23: 231-238.
48. Cardno AG, Jones LA, Murphy KC, Sanders RD, Asherson P, Owen MJ et al. Sibling pairs with schizophrenia or schizoaffective disorder-associations of subtypes, symptoms and demographic variables. Psychol Med 1998; 28: 815-823.
49. Maziade M, Bouchard S, Gingras N, Charron L, Cardinal A, Roy MA et al. Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. II: Postnegative distinction and childhood predictors of adult outcome. Br J Psychiatry 1996; 169: 371-378.
50. Chua SE, Wright IC, Poline JB, Liddle PF, Murray RM, Frackowiak RS et al. Grey matter correlates of syndromes in schizophrenia. A semi-automated analysis of structural magnetic resonance images. Br ) Psychiatry 1997; 170: 406-410.
51. Serretti A, Macciardi F, Smoraldi E. Dopamine receptor D2 Ser Cys311 variant associated with disorganized symptomatology of schizophrenia. Schizophr Res 1998; 34: 207-210.
52. Serretti A, Lilli R, Lorenzi C, Smeraldi E. Further evidence supporting the association behvecn the dopamine receptor D2 Ser/Cys311 variant and disorganized symptomatology of schizophrenia. Schizophr fles (in press).
53. Sasaki T, Macciardi FM, Badri F, Verga M, Meltzer HY, Lieberman J et al. No evidence for association of dopamine D2 receptor variant (Ser311/Cys311) with major psychosis. Am J Mcd Gen 1990; 67: 415-417.
54. Serretti A, Smeraldi E. Dopamine D2 receptor gene not associated with symptomatology of mood disorders. Am J Med Gen 1999; 88: 294-297.
55. Coryell W, Winokur G, Shea T, Maser J, Endicott J, Akiskal H. The long-term stability of depressive subtypes. Am J Psychiatry 1994; 151: 199-204.
56. Gasparini P, Estivill X, Volpini V, Totaro A, Castellvi-Bel S, Govea N et al. Linkage of DFNB1 to non-syndromic neurosensory autosomal-rccessive deafness in Mediterranean families. Eur J Hum Genet 1997; 5: 83-88.
57. Peralta V, Cuesta M, De Leon J. An empirical analysis of latent structures underlying schizophrenic symptoms: a four-syndrome model. Biol Psychiatry 1994; 30: 720-730.
58. Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM. Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry 1982; 39: 879-883.
59. Souery D, Lipp O, Mahieu B, Serretti A, Cavallini C, Ackenheil M et al. European Collaborative Project on Affective Disorders: Interactions between genetic and psychosocial vulnerability factors. Psychiatr Genet 1998; 8: 197-206.
60. McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry 1991; 48: 764-770.
61. Andreasen NC, Endicott J, Spitzer RL. The family history method using diagnostic criteria: reliability and validity. Arch Gen Psychiatry 1977; 34: 1229-1233.
62. Lahiri D, Nürnberger JJ. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acid Res 1991; 19: 5444.
63. Cardno AG, Jones LA, Murphy KG, Asherson P, Scott LC, Williams J et al. Factor analysis of schizophrenic symptoms using the OPCRIT checklist. Schizophr Res 1996; 22: 233-239.
64. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum Associates: Hillsdale, NJ, 1988.